Physician profile
Darwin L Brown
NPI 1992751259
$926.83
in general payments reported to CMS, 2019-2025
20 companies · $19.27 in 2025
The $19.27 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.22 · 2020: $32.69 · 2021: $33.66 · 2022: $129 · 2023: $587 · 2024: $107 · 2025: $19.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $139.20 | 2022-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $120.65 | 2023-2024 | Mounjaro, Lyumjev, Baqsimi |
| Xeris Pharmaceuticals, INC. | $112.04 | 2022-2023 | Gvoke Hypopen |
| Novo Nordisk INC | $77.79 | 2020-2024 | Wegovy, Rybelsus, Ozempic |
| Dexcom, INC. | $69.51 | 2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.34 | 2022-2024 | Jardiance |
| Radius Health, INC. | $50.99 | 2023-2024 | Tymlos |
| Sanofi-Aventis U.S. LLC | $45.71 | 2023 | |
| Ibsa Pharma INC. | $38.64 | 2023 | Tirosint, Licart |
| Abbvie INC. | $31.37 | 2023 | Synthroid |
| Medtronic, INC. | $30.28 | 2021-2023 | Minimed 780g |
| Insulet Corporation | $20.81 | 2023 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $19.66 | 2023 | Farxiga |
| Amneal Pharmaceuticals LLC | $19.34 | 2023 | Unithroid |
| Amgen INC. | $19.27 | 2025 | Tepezza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $18.45 | 2021 | |
| Medtronic Minimed, INC. | $18.22 | 2019 | |
| Tandem Diabetes Care, INC. | $15.69 | 2020 | |
| Kyowa Kirin, INC. | $14.03 | 2023 | |
| Cequr Corporation | $13.84 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darwin Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.